Skip to main content
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. logo

ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. — Investor Relations & Filings

Ticker · 300009 ISIN · CNE100000GY2 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,016 across all filing types
Latest filing 2020-08-25 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300009

About ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD.

https://www.ankebio.com

Anhui Anke Biotechnology (Group) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and commercialization of biopharmaceutical products. The company focuses on genetic engineering, cell therapy, and precision medicine. Its core product portfolio includes recombinant human growth hormone (rhGH) marketed under the brand Ansomone, and recombinant human interferon alpha-2b known as Anterferon. Anke Bio also develops diagnostic reagents, including biochemical and molecular diagnostic kits, and provides services in the fields of oncology and reproductive health. The company maintains a strong emphasis on innovation through its dedicated R&D centers, aiming to provide advanced therapeutic solutions for growth disorders, viral infections, and various cancers. Its operations span the entire value chain from basic research to clinical application and market distribution.

Recent filings

Filing Released Lang Actions
2020年半年度报告提示性公告
Report Publication Announcement Classification · 100% confidence The document is very short (327 characters) and is titled as a "2020 half-year report indicative announcement". It states that the company's 2020 half-year report and summary have been disclosed on the official information disclosure website and advises investors to check it. There is no actual financial data or detailed report content included, only a notice that the report has been published elsewhere. According to the MENU VS MEAL RULE, this is an announcement about the publication of a report, not the report itself. Therefore, the correct classification is Report Publication Announcement (RPA).
2020-08-25 Chinese
关于变更董事会秘书联系方式的公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding a change in contact information for the company's board secretary. It does not contain financial data, report content, or regulatory certifications. It specifically relates to a change in a board member's contact details, which falls under management or board information updates. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is very short (385 characters), confirming it is a brief announcement rather than a full report.
2020-08-25 Chinese
关于2020年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2020年半年度募集资金存放与使用情况专项报告" which translates to "2020 Half-Year Special Report on the Storage and Use of Raised Funds." It details the amount of funds raised, their storage, usage, and management for the half-year period ending June 30, 2020. The content includes specific financial figures related to fundraising, usage, bank accounts, and compliance with regulatory guidelines. The document is about the use and management of funds raised through non-public issuance, which aligns with a specialized report on capital/fundraising activities rather than a general financial report or earnings release. The document length is 3912 characters, which is relatively short but contains substantive financial data and detailed usage information, not just an announcement or a certification. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2020-08-25 Chinese
独立董事关于公司第七届董事会第四次会议相关事项的独立意见
Board/Management Information Classification · 90% confidence The document is an independent opinion statement from independent directors regarding the company's board meeting matters, specifically addressing the half-year period ending June 30, 2020. It discusses the review of related party transactions, external guarantees, and the use of raised funds. The document references compliance with laws and regulations and provides an independent opinion on these matters. It does not contain full financial statements or detailed financial analysis but rather an independent directors' report on specific governance and compliance issues related to the interim period. This fits best under Board/Management Information (MANG) as it relates to board meeting matters and independent directors' opinions on company governance and financial compliance issues for a specific period, rather than a full interim report or audit report. The document length is short and focused on governance opinions rather than comprehensive financial data, so it is not an Interim Report (IR) or Audit Report (AR).
2020-08-25 Chinese
关于第七届监事会第四次会议决议的公告
Report Publication Announcement Classification · 95% confidence The document is an announcement of the resolution passed by the Supervisory Board regarding the company's 2020 semi-annual report. It states that the Supervisory Board has reviewed and approved the 2020 half-year report and its summary, confirming compliance with laws and regulations. The document does not contain the actual financial statements or detailed financial data but refers readers to the full report available on the designated disclosure website. The document length is short (693 characters) and serves as a formal announcement of the approval and availability of the interim report rather than the report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the Interim/Quarterly Report (IR) itself.
2020-08-25 Chinese
关于公司部分董事、高级管理人员减持股份预披露公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding the planned reduction of shareholdings by certain company directors and senior management personnel. It details the shareholders involved, the number of shares to be reduced, the reasons for reduction, and compliance with relevant regulations. There is no financial data, earnings information, or report content. The document is a notification of insider share transactions by company directors and executives, fitting the definition of Director's Dealing (DIRS). The document length is short and focused solely on share reduction plans by insiders, confirming it is not a full report or earnings release.
2020-07-31 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.